COVID-19 Drug Treatments

1.3.1.  What drugs are used to treat COVID-19?  The FDA has approved one drug (Remdesivir) and granted emergency use authorization (EUA) to others for the treatment of COVID-19.  

1.3.1.1.  Remdesivir is the only drug approved by the FDA to treat COVID-19 for ages 12 and older.  Marketed as Veklury, Remdesivir is an antiviral drug that is given to COVID-19 patients requiring hospitalization.  It is administered by a healthcare provider by intravenous infusion once per day for up to 10 days.

1.3.1.2.  Monoclonal antibodies are laboratory-made molecules that act as substitute antibodies that can help your body recognize and fight the virus.  The FDA has issued EUAs for several types of monoclonal antibody treatments, including for use as a post-exposure preventitive treatment.

1.3.1.3. Ivermectin. The FDA reports “Currently available data do not show ivermectin is effective against COVID-19.” However, “Ivermectin was found to be safe and effective in treating adult patients with mild COVID-19” back in December 2020, as a large number of studies have also shown. As the effectiveness of Ivermectin as a COVID-19 treatment becomes even more apparent (e.g., in India and Africa), Big Pharma develops anti-virals to compete. Perhaps the Ivermectin smear campaign makes a little more cents now.